News from the web
- Category: Oncol
Campaign to control cancer - 10/28/10
Gordon Campbell may have been shuffling his cabinet on Monday, October 25, but Cancer Day of Action (CDA) volunteers made sure that his ministers’ realigning of priorities included talking about catastrophic drug coverage.
Even before the dust had settled, more than 20 MLAs of British Columbia’s Liberal party gave their full attention to 25 representatives from the Canadian Breast Cancer Foundation BC/Yukon, BC Cancer Agency, Colorectal Cancer Association of Canada, Leukemia & Lymphoma So
Read more...
- Category: Oncol
Journal of the National Cancer Institute - 08/13/10
Background: In the Women's Health Initiative (WHI) randomized controlled trial, use of estrogen plus progestin increased lung cancer mortality. We conducted post hoc analyses in the WHI trial evaluating estrogen alone to determine whether use of conjugated equine estrogen without progestin had a similar adverse influence on lung cancer.
Read more...
- Category: Oncol
Journal of the National Cancer Institute - 08/13/10
Use of estrogen alone did not increase lung cancer mortality in postmenopausal women, according to a study published online August 13 in The Journal of the National Cancer Institute.
In the Women’s Health Initiative (WHI) trial, which consisted of several clinical trials on postmenopausal women, one study showed women with
Read more...
- Category: Oncol
Lung Cancer News Today - 07/13/10
WASHINGTON, July 13 /PRNewswire-USNewswire/ -- Today, Lung Cancer Alliance (LCA) highlighted a study, carried out by Ipsos MORI on behalf of The Global Lung Cancer Coalition (GLCC). The study finds lung cancer patients are likely to suffer significant stigma due to the disease's link to smoking.
Over 16,000 people in 16 countries were asked questions about their attitudes surrounding lung cancer. The study found some evidence that sympathy levels were influenced by the smoking rates of each
Read more...
- Category: Oncol
ECPC - 06/23/10
On 23 June a new initiative of the European Cancer Patient Coalition (ECPC) entitled Forum Against Cancer Europe (FACE) was successfully launched at the European Parliament. The Forum Against Cancer Europe" (FACE) has been set up to continue the successful dialogue of the European cancer patient community with European Parliamentarians, Commission and all concerned stakeholders. It was launched with a workshop entitled "More Cancer Research Needed in the EU: Cancer Affects Almost Every Family".
Read more...
- Category: Oncol
ESMO News - 05/03/10
The First Line Iressa versus Carboplatin/Paclitaxel in Asia (Iressa Pan-Asia Study [IPASS]) study was a phase III, multicenter, randomized, open-label, parallel-group study comparing gefitinib with carboplatin plus paclitaxel as first-line treatment in clinically selected patients in East Asia who had advanced non–small-cell lung cancer. The primary end point was progression-free survival. Secondary end points included overall survival, the objective response rate, quality of life, reduction i
Read more...
- Category: Rights
Activecitizenship Network - 04/18/10
This 18th April we are celebrating throughout Europe the 4th European Patients’ Rights Day! Citizens and patients organisation from 16 European countries are taking part of this initiative to disseminate, inform, discuss and take commitments on improving patients’ rights in Europe...........
Read more...
- Category: Oncol
Medical News Today - 03/14/10
Pfizer Inc. announced today the discontinuation of A4021018 (also known as ADVIGO 1018), a Phase 3 trial examining the effects of investigational compound figitumumab (CP-751,871) in combination with erlotinib as a second/third-line treatment in patients with previously treated advanced non-adenocarcinoma non-small cell lung cancer (NSCLC).
Read more...
- Category: Oncol
UICC - 02/04/10
World Cancer Day 2010, led by UICC, its members and with the support of the World Health Organization (WHO), will raise awareness of cancer prevention.
Read more...
- Category: Oncol
The New York Times - 12/28/09
....................That was 20 years ago, and ever since, Dr. Bissell and a few others have struggled for acceptance of what seemed a radical idea: Gene mutations are part of the process of cancer, but mutations alone are not enough. Cancer involves an interaction between rogue cells and surrounding tissue....................
Read more...
- Category: Oncol
Lancet Student - 12/11/09
Since 1987, the breast cancer mortality rate in women has been surpassed by the lung cancer mortality rate, thus becoming the principal cause of cancer death.
Currently, more attention is concentrated in prevention and treatment of breast cancer while the high incidence and mortality of lung cancer in women has been largely neglected.......
Read more...
- Category: Oncologic
The roy castle Foundation - 11/11/09
Lung cancer is known as the “invisible” or “forgotten” disease but lung cancer is a stark reality for around 39,000 new patients in the UK every year. Lung cancer is the most common cancer in the world. Even more shocking, the average time from diagnosis to death is just six months.
Read more...
- Category: Oncologic
- 09/02/09
We began this summer with our third Addario Lung Cancer Medical Institute (ALCMI) Summit in concert with the 10th International Lung Cancer Congress in Hawaii, co-chaired by Drs. David Gandara and Roy Herbst. We rolled up our sleeves with the ALCMI Scientific Leadership Council (SLB) and guests. Please note: I simply can't call them a Scientific Advisory Board because they are not simply advising, they are LEADING revolutionary efforts to extend lives and eradicate Lung Cancer.
Read more...
- Category: Oncologic
VitalOptions - 08/06/09
The Group Room cancer talk radio show traveled to the 13th World Conference on Lung Cancer (WCLC) in San Francisco, CA on Sunday, August 2nd and produced a great program on the latest advances in lung cancer research.
Would your patients be interested in hearing the discussion? Add a link to our archive of the show to your website or newsletters and hear the news straight from the conference.
We chatted with:
Dr. Giorgio Scagliotti of the University of Turin
Dr. Ronald Natale of Sam
Read more...
- Category: Smoke
World Health Organization - 05/31/09
The theme of World No Tobacco Day 2009 is "Tobacco Health Warnings", with an emphasis on the picture warnings that have been shown to be particularly effective at making people aware of the health risks of tobacco use and convincing them to quit.......
Read more...
- Category: Smoke
World Health Organization - 05/31/09
On 31st May each year WHO celebrates World No Tobacco Day, highlighting the health risks associated with tobacco use and advocating for effective policies to reduce consumption. Tobacco use is the second cause of death globally and is currently responsible for killing one in 10 adults worldwide.
Read more...
- Category: Oncologic
TARCEVA-ERLOTINIB - 05/06/09
Rash and diarrhea were the most common side effects associated with Tarceva (erlotinib). They were generally mild to moderate. In a large clinical study, 66% of the patients receiving Tarceva experienced mild-to-moderate rash, while 48% of patients had mild-to-moderate diarrhea. In the NSCLC study, severe rash and diarrhea occurred in 9% and 6% of patients, respectively
Read more...
- Category: Oncologic
The New York Times - 04/23/09
is estimated that there were 215,020 new cases of lung cancer diagnosed in the United States in 2008, and 161,840 deaths. What is it like to live with the No. 1 cancer killer? Six men and women speak about living with lung cancer.
Read more...
- Category: Oncologic
National Lung Cancer Partnership - 04/22/09
Our visit to Dana-Farber last Thursday was really a wonderful thing. The thoracic oncologist agreed that it is time to stop cytotoxic chemotherapy and that it is not likely to be a useful treatment modality in the future for me. He also reminded us that, while I have this cancer in a lot of places, I don’t have a lot of it and none in any life-threatening locations (near major vessels, compromising my breathing, etc.) and that the biology of the cancer is just different in nonsmokers than in
Read more...
- Category: Oncologic
- 04/15/09
The Look Good…Feel Better program — developed in 1989 by the Personal Care Products Council Foundation, a charitable organization established by the Personal Care Products Council — actually began with one patient.
In 1987, a physician asked former Personal Care Products Council president Ed Kavanaugh how to get a “make-over..................
Read more...
- Category: Oncologic
- 04/15/09
Experiencing skin, facial and nail changes during cancer treatment? You can still be yourself. Our make-over expertise will show you the way to look good…feel better. To get a basic step-by-step approach right here online: just follow the numbers below. Then, for personal attention and hands-on tips from trained cosmetologists, attend a free LGFB group program near you. Join us to learn techniques and customize your look in a supportive atmosphere....
Read more...
- Category: Smoking
Medscape Today - 04/14/09
Two randomized controlled trials reported in the April 7 issue of the Annals of Internal Medicine examined cutting-edge strategies to improve the population impact of existing strategies for tobacco smoking cessation.
"Cigarette smoking is a chronic, relapsing illness that is inadequately addressed in primary care practice," write Edward F. Ellerbeck, MD, MPH, from University of Kansas Medical Center in Kansas City, and colleagues
Read more...
- Category: Oncologic
Medscape Today - 04/14/09
Among other issues, the Medicare Modernization Act (MMA) of 2003 sought to modernize reimbursement for cancer drugs and essential cancer-care services by reforming the payment systems for oncology. However, many feel that instead of fixing a "broken system," the situation might have actually worsened
Read more...
- Category: Oncologic
cbcnews.ca - 04/09/09
Health Canada has approved the use of a costly drug alongside chemotherapy for people with a type of lung cancer. Avastin (bevacizumab) works by restricting the growth of blood vessels that supply tumours with nutrients and oxygen....
Read more...
- Category: Oncologic
BBC News Channel - 04/03/09
Seventeen people die from lung cancer every week in Northern Ireland, according to new research.
Young women are still smoking too much, warned the report compiled by the Northern Ireland Cancer Registry and Queen's University Belfast.....
Read more...
- Category: Onologic
Thedailytimes.com - 03/15/09
What's the leading cause of cancer death in women in the United States? The answer might surprise you, because it is lung cancer, not breast cancer. According to the American Lung Association, lung cancer accounts for almost twice as many deaths as breast cancer. And while smokers are more likely to develop the disease, one in every five people with lung cancer has never touched a cigarette....
Read more...
- Category: Oncologic
Medscape Today - 01/01/09
Dr. Baile will talk to us today about communicating with cancer patients, focusing on those particularly delicate conversations that take place when the news is bad. Welcome, Dr. Baile.
Read more...
- Category: Oncologic
Science daily - 11/04/08
Minimally-invasive surgery for lung cancer called video-assisted thoracic surgery or VATS is a relatively new procedure performed almost exclusively at academic centers. Now, a preliminary study to be presented this month at the annual CHEST meeting in Philadelphia is giving surgeons an early look at its benefits....
Read more...
- Category: Oncologic
CancerCare - 10/28/08
CancerCare today announced that despite an overall increase in news reporting on lung cancer, the overall tone of lung cancer media coverage has become significantly more negative. "How the U.S. Media Report on Cancer" (supplement ), an analysis of lung, breast, colorectal and prostate cancer coverage, was an independent report conducted by CARMA International Inc. for CancerCare; previous analyses were issued in 2000 and 2004....
Read more...
- Category: Oncologic
National Lung Cancer Partnership - 10/01/08
Kathryn Joosten has just won her second Emmy for her role as Mrs. McClusky on ABC's Desperate Housewives and Ellen R. Gritz, Ph.D., member of the Partnership's Board of Directors and Scientific Executive Committee, was selected as the recipient of the 2008 Alma Dea Morani, M.D. Renaissance Woman Award from the Foundation for the History of Women in Medicine
Read more...
- Category: Oncologic
MedScape Today - 09/29/08
Smoking-related adenocarcinoma of the lung is now the most common cause of cancer death in the United States, according to findings presented at the American Society for Clinical Oncology (ASCO). Researchers also confirmed a gradual shift in the histology of lung cancer..................
Read more...
- Category: Oncologic
MedScape Today - 09/23/08
KM is a 62-year-old retired pilot who previously smoked approximately 1 pack of cigarettes per day for 21 years before quitting approximately 25 years ago. He was in his usual state of generally good health until he began to experience an increasing cough productive of yellow sputum for 2 months..........
Read more...
- Category: Oncologic
Medscape News - 09/13/08
The best responses to customized therapy with erlotinib in patients with non-small-cell lung cancer (NSCLC) are seen in those who have mutations in epidermal growth-factor receptor (EGFR), according to data presented here at the 33rd European Society for Medical Oncology Congress......
Read more...
- Category: Oncologic
MedScape Today - 08/29/08
Patients undergoing cancer treatments must often contend with the potentially life-threatening consequences of cytotoxic chemotherapy. Newer cancer treatments increasingly involve the use of targeted agents that inhibit epidermal growth factor receptor (EGFR). Although targeted agents are not associated with the toxicities typical of traditional antineoplastic agents, a wide range of cutaneous reactions and other bothersome adverse effects are seen in a majority of patients...............
Read more...
- Category: Oncologic
- 07/14/08
Sophie van der Stap was 21 years old when she was diagnosed with a rare form of cancer. A striking, fun loving student, overnight her world was reduced to the sterile confines of a hospital.
Read more...
- Category: Oncologic
Cancernews - 07/03/08
Prior to making treatment recommendations, the oncologist must assess an individual patient's ability to tolerate the various types of treatment that are available to treat cancer, including surgery, radiation therapy, and chemotherapy, used either alone or in combination with each other.....
Read more...
- Category: Oncologic
Medical news today - 07/03/08
A major study released in the Journal of Clinical Oncology has shown that doctors could increase the survival of patients with a specific type of lung cancer to over 12 months, if they match choice of chemotherapy with the type of tissue in a patient's tumour.
Read more...
- Category: Oncologic
Cancernews - 07/03/08
Resectability of the tumor depends on the type of cancer as well as the degree of invasion which is determined by characteristics of the primary tumor as well as the presence of lymph node or distant metastases.....
Read more...
- Category: Oncologic
Medical news today - 07/03/08
Massachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy.
Read more...
- Category: Oncologic
Cancernews - 07/03/08
Surgery remains the treatment of choice for patients with stage I and II (early stage) non-small cell lung cancer (NSCLC).(1,2) However, a substantial number of patients are medically inoperable because of other medical conditions, which can lead to higher rates of complications and deaths after surgery....
Read more...
- Category: Oncologic
Reuters - 07/03/08
Using a recently developed device, US researchers have shown that mutations in the epidermal growth factor receptor (EGFR) gene may arise in circulating lung cancer cells. The team believes that monitoring for such real-time changes could help guide and improve current cancer therapy.
Read more...
- Category: Oncologic
Medical news today - 06/20/08
An article in the July edition of The Lancet Oncology suggests that a common treatment for liver cancer - radiofrequency ablation - can also be used to treat lung cancer. A team of European and American researchers calls for randomized controlled trials in order to more robustly investigate this minimally invasive procedure for cancer treatment.
Read more...
- Category: Oncologic
CancerWise - 06/08/08
A common, inherited genetic variation may help explain why some smokers are more likely to develop lung cancer than others.
Read more...
- Category: Oncologic
Medical news today - 06/01/08
Tobacco smokers who eat three servings of fruits and vegetables per day and drink green or black tea may be protecting themselves from lung cancer, according to a first-of-its-kind study by UCLA cancer researchers.
Read more...
- Category: Oncologic
Medical news today - 05/29/08
Two types of cancer-causing agents in cigarettes a nicotine-derived chemical and polycyclic aromatic hydrocarbons (PAHs) are the main culprits in lung cancer.
Read more...
- Category: Oncologic
Medical news today - 05/18/08
Patients who have undergone surgical procedures for the removal of lung cancer can tolerate and benefit from exercise regimens started just a month after surgery, according to a new study led by researchers at the Duke Comprehensive Cancer Center.
Read more...
- Category: Oncologic
Reuters life - 05/16/08
WASHINGTON (Reuters Life!) - Adding a little extra chemotherapy after finishing the initial course helped advanced lung cancer patients live longer without having their tumors grow or come back, researchers reported on Thursday.......
Read more...
- Category: Oncologic
Medical news today - 05/07/08
Women who quit smoking significantly reduce risk of death from coronary heart disease within 5 years, but impact on risk of death from lung and other cancers take longer.
Read more...
- Category: Oncologic
Reuters Health - 05/06/08
NEW YORK (Reuters Health) - Deaths from vascular disease due to smoking are substantially reduced in women within 5 years after they quit smoking, according to findings from the Nurses' Health Study..........
Read more...
- Category: Oncologic
Reuters Health - 04/22/08
NEW YORK (Reuters Health) - Exercise appears to be beneficial for patients suffering from cancer-related fatigue, both during and after treatment, a review of published studies indicates...............
Read more...
- Category: Oncologic
Cancer news - 02/01/08
Researchers at UCLA’s Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.
Read more...
- Category: Oncologic
The Boston Globe - 05/20/07
A generation ago, cancer was a whispered death sentence, carried out in cloistered withdrawal. But now more people are living with cancer -- juggling jobs and treatments, time for love and tough life decisions......
Read more...
- Category: Oncologic
Cancernews - 03/06/07
The first report of an international study looking at computed tomography (CT) to screen current or former smokers for lung cancer found that screening did not reduce deaths from lung cancer...
Read more...
- Category: Oncologic
Cancernews - 12/12/06
Patients treated surgically for early-stage lung cancer face an increased risk of recurrence if their tumors contain a large number of cells that act as "dimmer switches" on the immune system, according to a study at Duke University Medical Center...
Read more...
- Category: Oncologic
Usa Today - 11/20/06
Though cancer can be a harrowing experience, a growing body of research suggests that the disease also changes many people's lives for the better. Nearly two out of three cancer survivors and their families say something good has come out of their experience, according to a new poll from USA TODAY/Kaiser Family Foundation/Harvard School of Public Health......
Read more...
Category:
- 00/00/00
Type here the news text...
Read more...
Category:
- 00/00/00
Type here the news text...
Read more...
- Category: Oncologic
Reuters - 00/00/00
An international research team has identified two genetic variations that appear to increase a person's risk of developing lung cancer by up to 60 percent, they reported on Sunday. In April the same researchers identified another gene..........
Read more...
Resources
(pdf 57kb)
